Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy C Sherman

Showing results (11-20 of 59) with videos related to

Pageof 6
Sort By:
Vaccine|October 8, 2025
Editorial for the special issue "Vaccines for the vulnerable"Asimenia Angelidou, Nicola Cotugno, Amy C Sherman, et al.
Vaccine|November 28, 2024
Biomarkers of vaccine safety and efficacy in vulnerable populations: Lessons from the fourth international precision vaccines conferenceDonato Amodio, Asimenia Angelidou, Nicola Cotugno, et al.
The New England Journal of Medicine|November 6, 2024
Two Sides to the StoryCody E Cotner, Richard M Stone, Amy C Sherman, et al.
Clinics in Laboratory Medicine|February 1, 2025
Molecular Diagnostics for Invasive Molds: From Lab to BedsideAlisse Hannaford, Ruben Alfonso Hernandez-Acosta, Jessica S Little, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 8, 2020
The Effect of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Mitigation Strategies on Seasonal Respiratory Viruses: A Tale of 2 Large Metropolitan Centers in the United StatesAmy C Sherman, Ahmed Babiker, Andrew J Sieben, et al.
AIDS Research and Human Retroviruses|December 25, 2012
Augmentation of hepatitis B virus-specific cellular immunity with programmed death receptor-1/programmed death receptor-L1 blockade in hepatitis B virus and HIV/hepatitis B virus coinfected patients treated with adefovirAmy C Sherman, Nirupama Trehanpati, Marybeth Daucher, et al.
Open Forum Infectious Diseases|May 25, 2026
Invasive Fusariosis: A Retrospective Case Series Evaluating In Vitro Minimum Inhibitory Concentrations and Clinical ResponseVictor Kovac, Sarah P Hammond, Nicolas C Issa, et al.
Vaccines|November 11, 2020
The Effects of Imprinting and Repeated Seasonal Influenza Vaccination on Adaptive Immunity after Influenza VaccinationAmy C Sherman, Lilin Lai, Mary Bower, et al.
Transplantation and Cellular Therapy|February 3, 2023
Impact of Donor and Recipient SARS-CoV-2 Vaccination or Infection on Immunity after Hematopoietic Cell TransplantationAmy C Sherman, Chi-An Cheng, Zoe Swank, et al.
Open Forum Infectious Diseases|December 15, 2021
Safety of Live-Attenuated Measles, Mumps, and Rubella Vaccine Administered Within 2 Years of Hematopoietic Cell TransplantMichaël Desjardins, Xhoi Mitre, Amy C Sherman, et al.
Pageof 6

Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
Vaccine|October 8, 2025
Editorial for the special issue "Vaccines for the vulnerable"Asimenia Angelidou, Nicola Cotugno, Amy C Sherman, et al.
Vaccine|November 28, 2024
Biomarkers of vaccine safety and efficacy in vulnerable populations: Lessons from the fourth international precision vaccines conferenceDonato Amodio, Asimenia Angelidou, Nicola Cotugno, et al.
The New England Journal of Medicine|November 6, 2024
Two Sides to the StoryCody E Cotner, Richard M Stone, Amy C Sherman, et al.
Clinics in Laboratory Medicine|February 1, 2025
Molecular Diagnostics for Invasive Molds: From Lab to BedsideAlisse Hannaford, Ruben Alfonso Hernandez-Acosta, Jessica S Little, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 8, 2020
The Effect of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Mitigation Strategies on Seasonal Respiratory Viruses: A Tale of 2 Large Metropolitan Centers in the United StatesAmy C Sherman, Ahmed Babiker, Andrew J Sieben, et al.
AIDS Research and Human Retroviruses|December 25, 2012
Augmentation of hepatitis B virus-specific cellular immunity with programmed death receptor-1/programmed death receptor-L1 blockade in hepatitis B virus and HIV/hepatitis B virus coinfected patients treated with adefovirAmy C Sherman, Nirupama Trehanpati, Marybeth Daucher, et al.
Open Forum Infectious Diseases|May 25, 2026
Invasive Fusariosis: A Retrospective Case Series Evaluating In Vitro Minimum Inhibitory Concentrations and Clinical ResponseVictor Kovac, Sarah P Hammond, Nicolas C Issa, et al.
Vaccines|November 11, 2020
The Effects of Imprinting and Repeated Seasonal Influenza Vaccination on Adaptive Immunity after Influenza VaccinationAmy C Sherman, Lilin Lai, Mary Bower, et al.
Transplantation and Cellular Therapy|February 3, 2023
Impact of Donor and Recipient SARS-CoV-2 Vaccination or Infection on Immunity after Hematopoietic Cell TransplantationAmy C Sherman, Chi-An Cheng, Zoe Swank, et al.
Open Forum Infectious Diseases|December 15, 2021
Safety of Live-Attenuated Measles, Mumps, and Rubella Vaccine Administered Within 2 Years of Hematopoietic Cell TransplantMichaël Desjardins, Xhoi Mitre, Amy C Sherman, et al.
Pageof 6